FDA IDE

RUTHERFORD, N.J., May 7, 2026 Glucotrack, Inc. announced the submission of an Investigational Device Exemption (IDE) application to the...

JACKSONVILLE, FL, May 04, 2026 Medical Microinstruments (MMI) has successfully treated the first patient in its FDA-approved REMIND clinical...

RUTHERFORD, N.J., March 27, 2026 GlucoTrack announced plans to submit an Investigational Device Exemption (IDE) application to the U.S....

CAMPBELL, CALIFORNIA | January 26, 2026 — Myra Vision, a Shifamed portfolio company, announced that the first patient has...

NES ZIONA, Israel, December 8, 2025 — EyeYon Medical Ltd. announced that the U.S. Food and Drug Administration (FDA)...

SEOUL, South Korea, Oct. 13, 2025 — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), a South Korea-based innovative medical device company,...

AURORA, Colo., Sept. 30, 2025 — Researchers at the University of Colorado Anschutz Medical Campus announced the first FDA-authorized...